Reply to: Methodologic reporting requirements for clinical trials?

G. A. Poland

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)9579
Number of pages1
JournalVaccine
Volume29
Issue number52
DOIs
StatePublished - Dec 6 2011

Fingerprint

clinical trials
Clinical Trials

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

Reply to : Methodologic reporting requirements for clinical trials? / Poland, G. A.

In: Vaccine, Vol. 29, No. 52, 06.12.2011, p. 9579.

Research output: Contribution to journalArticle

Poland, G. A. / Reply to : Methodologic reporting requirements for clinical trials?. In: Vaccine. 2011 ; Vol. 29, No. 52. pp. 9579.
@article{cd154f3d99b64a938a8c9d52081230d4,
title = "Reply to: Methodologic reporting requirements for clinical trials?",
author = "Poland, {G. A.}",
year = "2011",
month = "12",
day = "6",
doi = "10.1016/j.vaccine.2011.09.116",
language = "English (US)",
volume = "29",
pages = "9579",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "52",

}

TY - JOUR

T1 - Reply to

T2 - Methodologic reporting requirements for clinical trials?

AU - Poland, G. A.

PY - 2011/12/6

Y1 - 2011/12/6

UR - http://www.scopus.com/inward/record.url?scp=82555192814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82555192814&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2011.09.116

DO - 10.1016/j.vaccine.2011.09.116

M3 - Article

AN - SCOPUS:82555192814

VL - 29

SP - 9579

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 52

ER -